semaglutide and optic neuropathy Investigating the Link Between Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Non-arteritic Ischemic Neuropathy: A Case Report of Semaglutide-Induced Optic Semaglutide may increase risk for

The gastrointestinal side-effect burden is also comparable, sometimes worse at higher doses

Tirzepatide , initially approved for type 2 diabetes, has proven to be effective for significant weight loss in patients with obesity or those who are overweight with weight-related health issues

Take over-the-counter medications to relieve pain and itchiness If the injection has caused some pain, you can take over-the-counter (OTC) pain relievers, such as acetaminophen (Tylenol) or ibuprofen (Advil and Motrin) for relief

5.5 Appetite Suppression and Behavioral Weight Loss Programs 5.6 Potential Neuroprotective and Cognitive Benefits (Emerging Research) 5.7 Adjunct in Metabolic Syndrome Management 6